Yuki Noguchi
👤 SpeakerAppearances Over Time
Podcast Appearances
Vicki Stinson has defied odds typical for pancreatic cancer patients.
Arizona native was diagnosed at a late stage.
A doctor gave Stinson months, not years, to live.
Two years on, Stinson is alive and has felt well, thanks to a drug in a clinical trial, Deraxan RACIP, that is so promising, the Food and Drug Administration expanded access for patients prior to its approval.
Stinson notes there are other promising treatments as well.
It feels like it's so close, and I kind of feel like a ripe tomato.
And it's like, if I can just keep holding on for a little bit longer, this just might work for me.
Vicki Stinson has defied odds typical for pancreatic cancer patients.
The Arizona native was diagnosed at a late stage.
a doctor gave Stinson months, not years, to live.
Two years on, Stinson is alive and has felt well, thanks to a drug in a clinical trial, Deraxan RACIP, that is so promising, the Food and Drug Administration expanded access for patients prior to its approval.
Stinson notes there are other promising treatments as well.
It feels like it's so close, and I kind of feel like a ripe tomato on a vine.
keep holding on for a little bit longer, this just might work for me.
The drug Deraxanracib is in a class of genetically engineered medicines known as RAS inhibitors.
It identifies and kills pancreatic cancer cells using a genetic mutation common to that cancer.